George Tziras
Fortuna: 165 029 $ al 31/05/2026
Fortuna: 165 029 $ al 31/05/2026
George Tziras currently works at Small Pharma, Inc., as Chief Executive Officer & Director from 2022, Cybin UK Ltd., as Non-Executive Director from 2015, and Cybin, Inc., as Chief Business Officer from 2025.
Mr. Tziras also formerly worked at Unilock Capital Corp., as Chief Business Officer & Director.
Mr. Tziras received his undergraduate degree from the University of Oxford and graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CYBIN, INC. 0,07 % | 20/02/2026 | 36.270 ( 0,07 % ) | 165 029 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SMALL PHARMA INC. | Director Ejecutivo | 20/07/2022 |
| CYBIN INC. | Corporate Officer/Principal | 23/10/2023 |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Director/Miembro de la Junta | 01/01/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| SMALL PHARMA INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.